ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0195

Fibroblast HDAC1-Mediated Cytokine Contributes to Fibrosis After Kidney Ischemia-Reperfusion Injury

Session Information

  • AKI: Mechanisms - 2
    November 07, 2025 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms

Authors

  • Nguyen, Huy, The University of Alabama at Birmingham, Birmingham, Alabama, United States
  • Hyndman, Kelly A., The University of Alabama at Birmingham, Birmingham, Alabama, United States
Background

Ischemia-reperfusion injury (IRI) can cause acute kidney injury (AKI) and progression to chronic kidney disease (CKD) that is characterized by renal interstitial fibrosis. Histone deacetylase 1 (HDAC1), an epigenetic regulator of transcription, is activated following IRI and we hypothesize that fibroblast/pericyte HDAC1 activation contributes to in part by enhancing the secretion of pro-inflammatory cytokines and chemokines.

Methods

Male HDAC1fl/fl (littermate control) (n=13), and floxed mice positive for hemizygous Col1A2-CreER (iFibHDAC1KO mice) (n=17) were used. All mice received tamoxifen i.p. in adulthood and this resulted in fibroblast/pericyte HDAC1 knockdown in Cre positive mice. Subsets of mice underwent 18-minute kidney bilateral IRI or sham surgery. Acute kidney injury was confirmed 24 hours post-injury by measuring glomerular filtration rate. Interstitial fibrosis was evaluated after four weeks using picrosirius red staining, and quantification of fibronectin, collagen-1, and alpha smooth muscle actin (aSMA. Normal rat kidney fibroblasts (NRK-49F) were transfected with either an empty vector or HDAC1 for 24h. Cytokine/chemokine secretion in the culture media was determined.

Results

The severity of the AKI was similar among the genotypes as GFR 24 h post IRI was reduced by ~50% in all mice (p=0.99). Four weeks post-IRI, iFibHDAC1KO mice showed significantly attenuated renal fibrosis compared to control groups (p<0.0001). In the kidney cortex, % fibronectin area in iFibHDAC1KO-IRI (KO-IRI) mice (0.29%+0.23) was significantly lower than control-IRI group (1.11%+0.96, p=0.0055), as was collagen-1 (iFibHDAC1KO-IRI 0.14%+0.073 vs control-IRI 0.33%+0.25, p=0.02). In contrast, αSMA-positive area was not significantly different between genotypes in either the cortex, iFibHDAC1KO-IRI (4.0% ± 3.9) vs control (1.6% ± 1.5, p=0.09). HDAC1 overexpression in NRK-49F cells increased cytokine/chemokine secretion, including 54 pro-inflammatory and 21 anti-inflammatory cytokines/chemokines.

Conclusion

Fibroblast-specific HDAC1 knockdown attenuates renal fibrosis after IRI. Conversely, HDAC1 activation is pro-fibrotic by altering cytokine/chemokine secretion toward more inflammatory state, supporting HDAC1 as a potential therapeutic target to prevent fibrosis and AKI-to-CKD progression.

Funding

  • NIDDK Support

Digital Object Identifier (DOI)